Researchers at Moffitt Cancer Center and colleagues have identified PHF20, a novel transcriptional factor, and clarified its role in maintaining the stability and transcription of p53, a gene that allows for both normal cell ...
Aug 24, 2012
0
0
Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center study published in the journal ...
Apr 18, 2024
0
4
Hurricanes and other extreme weather events pose immediate threats to life and property and have long-lasting impacts on health outcomes, particularly for cancer survivors.
Feb 22, 2024
0
8
Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis, especially in advanced stages. Because of its rarity, few studies focus on better understanding and managing this disease.
Feb 16, 2024
0
0
Multiple myeloma remains challenging to treat. New therapeutic advances have improved outcomes, but selecting the right treatment for a patient can be complex because the disease can vary drastically from person to person. ...
Feb 9, 2024
0
0
Patient-reported outcomes are important indicators of how cancer drugs impact patients' lives. By assessing the benefits and risks of drugs from a patient's perspective, scientists and physicians can improve the development ...
Feb 6, 2024
0
0
Cutaneous melanoma is considered the deadliest form of skin cancer because it's aggressive and tends to spread quickly through the body. While scientists have made significant progress in understanding the molecular mechanisms ...
Jan 9, 2024
0
0
Checkpoint inhibitors that activate the immune system to target cancer cells for destruction have revolutionized the treatment landscape for patients with advanced melanoma, leading to more options and improved patient survival. ...
Dec 8, 2023
0
0
Most cancer deaths are due to the metastatic spread and growth of tumor cells at distant sites. Identifying appropriate treatments for patients with metastatic disease is challenging because of limited biomarkers and detection ...
Aug 15, 2023
0
7
One in eight women will develop breast cancer in their lifetime. The disease is treatable, especially when caught early. But what is the impact of breast cancer later in life? A Moffitt Cancer Center researcher, in collaboration ...
Jul 19, 2023
0
26
